Laith L. Yaldoo, Director at Zivo Bioscience, Inc. (ZIVO), bought 3,133 shares at $0.16 ($500) on 2024-10-16, disclosed to the SEC on 2024-10-17.
Open-market purchase of $500 ZIVO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ZIVO | BUY | 2026-01-27 | $15K | — | Filing → |
| ZIVO | BUY | 2025-12-02 | $25K | — | Filing → |
| ZIVO | BUY | 2025-10-14 | $20K | — | Filing → |